Boise News Today | 2 Min News | The Daily News Now!
A Virginia federal judge has struck down the FDA’s 2023 restrictions on mifepristone, ruling the agency failed to properly justify rules like prescriber certification and risk disclosures — calling them arbitrary and medically unnecessary. This follows a similar Hawaii court decision, forcing the FDA to revisit its justifications. Abortion care providers celebrate the ruling as a win against burdensome paperwork, freeing up time for patients. Meanwhile, the Biden administration’s 2023 mail-order expansion of mifepristone — which boosted access in restrictive states — continues to face legal challenges from anti-abortion groups seeking tighter controls. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/ae336fdbd7832776
300 Episoder
Kommentarer
0Vær den første til å kommentere
Registrer deg nå og bli medlem av Boise News Today | 2 Min News | The Daily News Now! sitt community!